# A Pharmacokinetics (PK) Study in Healthy Adults

> **NCT06911216** · EARLY_PHASE1 · COMPLETED · sponsor: **Santen Pharmaceutical Co., Ltd.** · enrollment: 8 (actual)

## Conditions studied

- Blepharoptosis

## Interventions

- **DRUG:** STN1013800 ophthalmic solution

## Key facts

- **NCT ID:** NCT06911216
- **Lead sponsor:** Santen Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-17
- **Primary completion:** 2025-04-07
- **Final completion:** 2025-04-07
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06911216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06911216, "A Pharmacokinetics (PK) Study in Healthy Adults". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06911216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*